Keri R. Maher, DO, MS is an associate professor of medicine at Virginia Commonwealth University Massey Cancer Center. She specializes in acute leukemia both clinically and academically and is the director of the Acute Leukemia Program and associate member of the Developmental Therapeutics team at Massey Cancer Center. She is also the Early Phase Disease Working Group Faculty Leader for Hematology. She is passionate about health disparities research in acute leukemias, where she focuses her research on relapse prevention strategies. She is a proud recipient of the Robert A. Winn Diversity in Clinical Trials Career Development Award.
Dr. Maher is board certified in internal medicine, hematology, and medical oncology. She completed her residency and fellowship at the University of Arizona in Tucson. She also received additional training in cellular therapy and hematopoietic transplant at Seattle Cancer Care Alliance/Fred Hutchinson Cancer Center in Seattle, Washington.
